Clinical Trials Logo

Canthal Lines clinical trials

View clinical trials related to Canthal Lines.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05148000 Completed - Clinical trials for Glabellar Frown Lines

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Start date: January 23, 2023
Phase: Phase 3
Study type: Interventional

This study to assess aesthetic improvement following treatment with QM1114-DP.

NCT ID: NCT01308060 Completed - Canthal Lines Clinical Trials

A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET)

Start date: January 2011
Phase: Phase 3
Study type: Interventional

This double-blind study has two parts for each subject (same population): Part A: initial treatment in Lateral Canthal Lines (LCL) (placebo-controlled): - To assess the efficacy and safety of Azzalure® compared to placebo in the improvement of moderate to severe LCLs. - To assess the subjects' level of satisfaction with the appearance of their LCLs compared to placebo. Part B: repeated treatment in LCL with or without Glabellar Lines (GL) (active treatment, up to 1 year): - To assess safety of Azzalure® following repeated administration in the improvement of moderate to severe LCLs. - To assess the safety of Azzalure® when used concomitantly for improvement of moderate to severe LCLs and GLs. - To assess the subjects' level of satisfaction with the appearance of their LCLs.